SC 13G/A | 2024-02-09 | FMR LLC | XOMA Corp | 1,155,033 | 10.1% | EDGAR |
SC 13D/A | 2024-01-16 | BIOTECHNOLOGY VALUE FUND L P | XOMA Corp | 1,789,844 | 15.6% | EDGAR |
SC 13G/A | 2023-02-09 | FMR LLC | XOMA Corp | 1,246,686 | 10.9% | EDGAR |
SC 13G/A | 2022-08-10 | FMR LLC | XOMA Corp | 1,163,088 | 10.2% | EDGAR |
SC 13G/A | 2022-02-14 | Eagle Point Credit Management LLC | XOMA Corp | 0 | 0.0% | EDGAR |
SC 13G | 2022-02-09 | FMR LLC | XOMA Corp | 887,522 | 7.8% | EDGAR |
SC 13G | 2021-04-19 | Eagle Point Credit Management LLC | XOMA Corp | 149,248 | 6.3% | EDGAR |
SC 13D/A | 2021-04-02 | BIOTECHNOLOGY VALUE FUND L P | XOMA Corp | 1,760,384 | 15.6% | EDGAR |
SC 13D/A | 2020-12-15 | BIOTECHNOLOGY VALUE FUND L P | XOMA Corp | 2,040,124 | 18.5% | EDGAR |
SC 13D/A | 2020-10-09 | BIOTECHNOLOGY VALUE FUND L P | XOMA Corp | 2,040,124 | 18.5% | EDGAR |
SC 13D/A | 2020-09-23 | BIOTECHNOLOGY VALUE FUND L P | XOMA Corp | 2,040,124 | 18.5% | EDGAR |
SC 13G/A | 2020-08-19 | NOVARTIS AG | XOMA Corp | 539,131 | 4.9% | EDGAR |
SC 13D/A | 2020-04-17 | BIOTECHNOLOGY VALUE FUND L P | XOMA Corp | 1,934,615 | 17.6% | EDGAR |
SC 13D/A | 2020-03-18 | BIOTECHNOLOGY VALUE FUND L P | XOMA Corp | 1,921,912 | 18.5% | EDGAR |
SC 13D/A | 2020-02-13 | BIOTECHNOLOGY VALUE FUND L P | XOMA Corp | 1,803,635 | 17.3% | EDGAR |
SC 13D/A | 2019-12-23 | BIOTECHNOLOGY VALUE FUND L P | XOMA Corp | 1,147,676 | 11.8% | EDGAR |
SC 13G/A | 2019-07-10 | BlackRock Inc. | XOMA Corp | 160,680 | 1.8% | EDGAR |
SC 13G | 2019-02-08 | BlackRock Inc. | XOMA Corp | 508,672 | 6.1% | EDGAR |
SC 13D/A | 2018-12-21 | BIOTECHNOLOGY VALUE FUND L P | XOMA Corp | 694,961 | 8.0% | EDGAR |
SC 13G | 2018-04-30 | XOMA Corp | Rezolute, Inc. | 8,093,010 | 13.0% | EDGAR |